Healthline

Triple Therapy Inhaler for COPD: What Is It?

Triple therapy for COPD combines three inhaled medications to help you breathe easier. This can include medications to reduce swelling, widen the airway, and relax the muscles in your airway. To treat ...
Renal & Urology News

Extrafine Single Inhaler Triple Therapy Is Effective in Patients With COPD

Among patients with chronic obstructive pulmonary disease who received prior treatment with multiple-inhaler triple therapy, single-inhaler triple therapy was effective in improving health status and ...
Healio

Initiating single-inhaler triple therapy for COPD improved persistence, outcomes vs. multiple inhalers

Please provide your email address to receive an email when new articles are posted on . Initiating single-inhaler triple therapy for COPD, compared with multiple-inhaler triple therapy, resulted in ...
Healio

Single vs. multiple inhaler COPD triple therapy decreases risk of cardiopulmonary events

Please provide your email address to receive an email when new articles are posted on . The single inhaler combined budesonide, glycopyrrolate and formoterol fumarate. The risk for cardiopulmonary ...
The American Journal of Managed Care

Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms

Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not ...
The American Journal of Managed Care

Individualizing Medication Therapy in Patients with COPD: Considerations with Inhalers

Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD. Jeffrey D. Dunn ...
Monthly Prescribing Reference

Single-Inhaler Triple Therapy Reduces Composite AE Risk vs Dual Therapy in COPD

Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...
Becker's Hospital Review

FDA approves Glaxo’s triple therapy inhaler for COPD

The FDA approved United Kingdom-based GlaxoSmithKline’s Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic obstructive pulmonary disease. The inhaler, developed with the ...
Medscape

Single-Inhaler Triple Therapy vs Dual Bronchodilators: Which Is More Effective for COPD?

The IMPACT and ETHOS trials showed that single-inhaler triple therapy significantly reduce the rate of COPD exacerbation and mortality compared with dual bronchodilators. Findings are from an ...
The New England Journal of Medicine

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β 2-agonist (LABA) for chronic obstructive pulmonary disease (COPD) have been ...
Monthly Prescribing Reference

Single-Inhaler Therapy vs Multiple-Inhaler Triple Therapy Outcomes in COPD

Inhalers In patients with COPD, treatment with single-inhaler fluticasone furoate/umeclidinium/vilanterol resulted in more health status improvements and greater lung ...